Search

Search Constraints

You searched for: Author/Creator Moore, Gregory

Search Results

13. Entyvio lengthen dose-interval study: lengthening vedolizumab dose interval and the risk of clinical relapse in inflammatory bowel disease. Issue 7 (July 2018)

14. Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial. (February 2022)

15. Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials. (January 2022)

17. Examining maintenance care following infliximab salvage therapy for acute severe ulcerative colitis. Issue 1 (28th December 2017)

18. Human amnion epithelial cells and their soluble factors reduce liver fibrosis in murine non‐alcoholic steatohepatitis. Issue 8 (2nd April 2019)

19. In Vivo Characteristics of Nondegenerated Adjacent Segment Intervertebral Foramina in Patients With Degenerative Disc Disease During Flexion-Extension. Issue 6 (15th March 2017)